BioPharma Credit Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	810	769	838	859	1,040	982
Market Cap Growth	8.07%	-8.31%	-2.43%	-17.41%	5.90%	-2.00%
Enterprise Value	801	765	809	806	1,031	892
Last Close Price	0.72	0.63	0.59	0.49	0.52	0.42
PE Ratio	8.44	7.96	8.59	10.09	6.87	15.65
PS Ratio	6.91	6.56	7.00	8.06	5.74	12.80
PB Ratio	0.95	0.90	0.89	0.82	0.94	0.98
P/TBV Ratio	0.95	0.90	0.89	0.82	0.94	0.98
P/OCF Ratio	11.97	11.36	9.38	8.88	6.80	13.79
EV/Sales Ratio	6.78	6.53	6.75	7.56	5.70	11.62
EV/EBIT Ratio	8.23	7.93	8.29	9.46	6.82	14.21
Net Debt / Equity Ratio	-0.01	-0.01	0.00	-0.10	-0.09	-0.07
Asset Turnover	0.13	0.13	0.12	0.10	0.16	0.08
Quick Ratio	3.77	3.77	2.09	9.79	5.34	16.51
Current Ratio	3.77	3.77	2.09	9.79	5.34	16.51
Return on Equity (ROE)	11.14%	11.14%	9.69%	8.10%	13.50%	6.19%
Return on Assets (ROA)	6.85%	6.85%	5.97%	4.98%	8.33%	3.85%
Return on Capital Employed (ROCE)	11.30%	11.30%	10.30%	8.10%	13.60%	6.20%
Earnings Yield	11.92%	12.56%	11.64%	9.91%	14.55%	6.39%
Dividend Yield	10.39%	8.20%	9.49%	11.21%	11.15%	12.35%
Payout Ratio	61.56%	61.56%	89.23%	63.58%	52.52%	113.20%
Buyback Yield / Dilution	6.77%	6.77%	6.65%	4.00%	0.72%	0.00%
Total Shareholder Return	17.16%	14.97%	16.14%	15.21%	11.87%	12.35%